share_log

醫思健康：授出豁免嚴格遵守上市規則第14.41(A)條

EC HEALTHCARE: GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES

香港交易所 ·  Mar 28 07:38
Summary by Moomoo AI
醫思健康（EC Healthcare）於2024年3月28日宣布，獲香港聯合交易所有限公司（聯交所）授予豁免，允許其豁免嚴格遵守上市規則第14.41(A)條。此豁免與公司先前宣布的收購新亞額外權益相關，該交易構成一項主要交易。公司正在編製相關通函，特別是新亞的財務報表，需時至2023年12月31日。由於新委任的核數師需要更多時間來完成審核程序，包括審閱新亞的過往數據及審核調整，因此獲得豁免。根據豁免條件，醫思健康須於2024年4月30日或之前將通函寄發給股東。聯交所可能會根據公司情況的變化，撤回或更改此豁免。公告由公司秘書蕭鎮邦發出，並指出公司執行董事包括鄧志輝先生、呂聯煒先生及李向榮先生，非執行董事為陸韵晟先生，獨立非執行董事為馬清楠先生、陸東先生及區雋先生。
醫思健康（EC Healthcare）於2024年3月28日宣布，獲香港聯合交易所有限公司（聯交所）授予豁免，允許其豁免嚴格遵守上市規則第14.41(A)條。此豁免與公司先前宣布的收購新亞額外權益相關，該交易構成一項主要交易。公司正在編製相關通函，特別是新亞的財務報表，需時至2023年12月31日。由於新委任的核數師需要更多時間來完成審核程序，包括審閱新亞的過往數據及審核調整，因此獲得豁免。根據豁免條件，醫思健康須於2024年4月30日或之前將通函寄發給股東。聯交所可能會根據公司情況的變化，撤回或更改此豁免。公告由公司秘書蕭鎮邦發出，並指出公司執行董事包括鄧志輝先生、呂聯煒先生及李向榮先生，非執行董事為陸韵晟先生，獨立非執行董事為馬清楠先生、陸東先生及區雋先生。
EC Healthcare (EC Healthcare) announced on 28 March 2024 that it has granted an exemption to the Hong Kong Stock Exchange Limited (HKEx), allowing its exemption to comply strictly with section 14.41 (A) of the Listing Rules. THIS EXEMPTION RELATES TO THE COMPANY'S PREVIOUSLY ANNOUNCED ACQUISITION OF ADDITIONAL INTERESTS IN NEW ASIA, WHICH CONSTITUTES A MAJOR TRANSACTION. The Company is preparing related circulars, in particular financial statements for New Asia, until 31 December 2023. The exemption was granted as the newly appointed auditor would need more time to complete the audit process, including a review of New Asia's past data and audit adjustments. Under the terms of the exemption, Doctor Health is required to send a circular to shareholders on or before April...Show More
EC Healthcare (EC Healthcare) announced on 28 March 2024 that it has granted an exemption to the Hong Kong Stock Exchange Limited (HKEx), allowing its exemption to comply strictly with section 14.41 (A) of the Listing Rules. THIS EXEMPTION RELATES TO THE COMPANY'S PREVIOUSLY ANNOUNCED ACQUISITION OF ADDITIONAL INTERESTS IN NEW ASIA, WHICH CONSTITUTES A MAJOR TRANSACTION. The Company is preparing related circulars, in particular financial statements for New Asia, until 31 December 2023. The exemption was granted as the newly appointed auditor would need more time to complete the audit process, including a review of New Asia's past data and audit adjustments. Under the terms of the exemption, Doctor Health is required to send a circular to shareholders on or before April 30, 2024. The Exchange may withdraw or amend this exemption depending on changes in the Company's situation. The announcement was issued by the Company Secretary, Mr. Xiao Zhenbang, and stated that the Executive Directors of the Company include Mr. Tang Chi-hui, Mr. Lu Lien Wei and Mr. Li Shuangwing. The Non-Executive Director is Mr. Lu Yun-sheng and the Independent Non-Executive Directors are Mr. Ma Ching Nan, Mr. Lu Dong and Mr. Wu Chun.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more